Trade Summary

2 weeks ago, Gsk Plc, serving as 10% owner at Wave Life Sciences Ltd. (WVE), purchased 1,470,000 shares at $19.00 per share, for a total transaction value of $27,930,000.00. Following this transaction, Gsk Plc now holds 18,245,691 shares of WVE.

This purchase represents a 9.00% increase in Gsk Plc's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, December 11, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 15, 2025, 4 days after the trade was made.

Wave Life Sciences Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.